Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

692 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer.
Kasivisvanathan V, Dufour R, Moore CM, Ahmed HU, Abd-Alazeez M, Charman SC, Freeman A, Allen C, Kirkham A, van der Meulen J, Emberton M. Kasivisvanathan V, et al. Among authors: moore cm. J Urol. 2013 Mar;189(3):860-6. doi: 10.1016/j.juro.2012.10.009. Epub 2012 Oct 11. J Urol. 2013. PMID: 23063807
Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group.
Moore CM, Kasivisvanathan V, Eggener S, Emberton M, Fütterer JJ, Gill IS, Grubb Iii RL, Hadaschik B, Klotz L, Margolis DJ, Marks LS, Melamed J, Oto A, Palmer SL, Pinto P, Puech P, Punwani S, Rosenkrantz AB, Schoots IG, Simon R, Taneja SS, Turkbey B, Ukimura O, van der Meulen J, Villers A, Watanabe Y; START Consortium. Moore CM, et al. Eur Urol. 2013 Oct;64(4):544-52. doi: 10.1016/j.eururo.2013.03.030. Epub 2013 Mar 20. Eur Urol. 2013. PMID: 23537686
A randomized controlled trial to investigate magnetic resonance imaging-targeted biopsy as an alternative diagnostic strategy to transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer.
Kasivisvanathan V, Arya M, Ahmed HU, Moore CM, Emberton M. Kasivisvanathan V, et al. Among authors: moore cm. Urol Oncol. 2015 Mar;33(3):156-7. doi: 10.1016/j.urolonc.2014.12.003. Epub 2015 Jan 5. Urol Oncol. 2015. PMID: 25573054 No abstract available.
Development and Phantom Validation of a 3-D-Ultrasound-Guided System for Targeting MRI-Visible Lesions During Transrectal Prostate Biopsy.
Hu Y, Kasivisvanathan V, Simmons LA, Clarkson MJ, Thompson SA, Shah TT, Ahmed HU, Punwani S, Hawkes DJ, Emberton M, Moore CM, Barratt DC. Hu Y, et al. Among authors: moore cm. IEEE Trans Biomed Eng. 2017 Apr;64(4):946-958. doi: 10.1109/TBME.2016.2582734. Epub 2016 Jun 21. IEEE Trans Biomed Eng. 2017. PMID: 27337710 Free PMC article.
692 results